用于监测抗吸收药物治疗骨质疏松症的骨转换标志物。 - Suppr

Suppr

超能文献

Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs.

作者信息

Delmas P D

机构信息

Inserm Research Unit 403 and Claude Bernard University of Lyon, France.

出版信息

Osteoporos Int. 2000;11 Suppl 6:S66-76. doi: 10.1007/s001980070007.

DOI:10.1007/s001980070007

PMID:11193241

Abstract

摘要

相似文献

Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs.

Osteoporos Int. 2000;11 Suppl 6:S66-76. doi: 10.1007/s001980070007.

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

Osteoporos Int. 2000;11 Suppl 6:S2-17. doi: 10.1007/s001980070002.

Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.

Spine J. 2018 Oct;18(10):1877-1887. doi: 10.1016/j.spinee.2018.05.020. Epub 2018 May 21.

Biochemical bone markers.

CAP Today. 1999 May;13(5):70-2, 74-8, 78-9.

Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosis.

Endocr J. 2008 Mar;55(1):127-34. doi: 10.1507/endocrj.k07e-027. Epub 2008 Jan 24.

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial.

Osteoporos Int. 2003 Oct;14(10):793-800. doi: 10.1007/s00198-003-1424-1. Epub 2003 Aug 29.

Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.

Osteoporos Int. 1999;10(4):330-6. doi: 10.1007/s001980050236.

Bone mineral density and biochemical markers of bone turnover in peri- and postmenopausal women.

Calcif Tissue Int. 2000 Apr;66(4):263-7. doi: 10.1007/s002230010053.

Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.

Endocr Regul. 2003 Dec;37(4):225-38.

Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.

Drugs. 2006;66(16):2031-58. doi: 10.2165/00003495-200666160-00001.

引用本文的文献

Clinical practice guidelines for full-cycle standardized management of bone health in breast cancer patients.

Cancer Innov. 2024 Feb 29;3(1):e111. doi: 10.1002/cai2.111. eCollection 2024 Feb.

The Effect of a Moderate Exercise Program on Serum Markers of Bone Metabolism in Dogs.

Animals (Basel). 2020 Aug 23;10(9):1481. doi: 10.3390/ani10091481.

Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.

Bone Rep. 2020 Apr 25;12:100275. doi: 10.1016/j.bonr.2020.100275. eCollection 2020 Jun.

Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension.

Yonsei Med J. 2016 Jul;57(4):905-14. doi: 10.3349/ymj.2016.57.4.905.

Effect of Nasal Calcitonin on the Health-Related Quality of Life in Postmenopause Women Affected With Low Bone Density.

Iran Red Crescent Med J. 2015 Jul 31;17(7):e6613. doi: 10.5812/ircmj.17(5)2015.6613. eCollection 2015 Jul.

Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.

Nutr Res Rev. 2014 Dec;27(2):252-67. doi: 10.1017/S0954422414000183. Epub 2014 Nov 14.

Cathepsin K in treatment monitoring following intravenous zoledronic acid.

Biomed Rep. 2014 Nov;2(6):915-917. doi: 10.3892/br.2014.360. Epub 2014 Sep 10.

Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis.

Osteoporos Int. 2014 Apr;25(4):1401-10. doi: 10.1007/s00198-014-2619-3. Epub 2014 Feb 8.

Nitrates and bone turnover (NABT) - trial to select the best nitrate preparation: study protocol for a randomized controlled trial.

Trials. 2013 Sep 8;14:284. doi: 10.1186/1745-6215-14-284.

Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis.

Ann Lab Med. 2012 Mar;32(2):105-12. doi: 10.3343/alm.2012.32.2.105. Epub 2012 Feb 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验